Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

March 31, 2006

Conditions
ThrombocytopeniaThrombosis
Interventions
DRUG

Argatroban

Trial Locations (13)

19104

Children's Hospital of Philadelphia, Philadelphia

40202

Kosair Children's Hospital, University of Louisville, Louisville

44106

Rainbow Babies at Children's Hospital, Cleveland

48109

Michigan Congenital Heart Center, Ann Arbor

60612

Rush University Medical Center, Chicago

60637

University of Chicago Children's Hospital, Chicago

61614

Children's Hospital of Illinois, Peoria

84113

Primary Children's Medical Center, Salt Lake City

90095

Mattel Children's Hospital at UCLA, Los Angeles

92868

Children's Hospital of Orange County, Orange

97201

Oregon Health & Science University, Portland

98105

Children's Hospital and Regional Medical Center, Seattle

02115

Children's Hospital of Boston, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Encysive Pharmaceuticals

INDUSTRY